Clinical trial

Protective Effect of Beraprost Sodium Tablets on Reperfusion Therapy for Acute STEMI

NCT05103813

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2022-05-01

PhaseEARLY_PHASE1

Study timeline

Study start (estimated)2022-05-01Date precision: day

Registry last updated2022-02-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Essential Hypertensionunresolved

Interventions

Beraprost Sodium TabletsDRUG

Sponsors & collaborators

Shenzhen People's Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05103813 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.